$DLB

Dolby Laboratories and Hisense said Dolby Vision 2 is rolling out on select Hisense smart TVs via firmware. The initial models include Hisense 2026 UX, UR9, UR8 and U7 series (U7 Pro in some regions) in North America, Europe and Asia-Pacific, with more updates planned. Dolby Vision 2 adds a new image engine, Content Intelligence, and an intensity slider, with Dolby Vision 2 Max adding features like Authentic Motion and Light Sense 2.

Dolby Laboratories (NYSE: DLB) shares rose about 12.6% in late July as investors reacted to results and raised guidance. The company reported Q3 adjusted EPS of $0.69 vs $0.67 consensus, revenue of $305M vs about $312M expected, and increased its buyback authorization by $350M. Free cash flow was about $152M, supporting dividends and repurchases.

Dolby Laboratories’ Q3 2026 earnings call said it is shifting toward content platforms and usage-based revenue, targeting 10% of total revenue from partners by FY2028. Management cited traction for its Video Distribution Program, including Meta and Alibaba deals, and a China-first automotive strategy. Q4 guidance calls for 23% YoY revenue growth, with a $4M restructuring charge and a $350M share repurchase authorization increase.

Dolby Laboratories (NYSE: DLB) shares rose 11.7% by 10:45 a.m. ET after its fiscal Q3 2026 results. The company reported revenue of $305 million versus an estimated $312 million, and EPS of $0.69 versus $0.67 expected. GAAP EPS was $0.30. Dolby guided Q4 sales to $362 million-$392 million and full-year revenue to at least $1.4 billion.

Thursday, July 30, 2026 at 5:00 p.m. ET CALL PARTICIPANTS Vice President of Investor Relations - Peter L. Goldmacher Chief Executive Officer - Kevin J. Yeaman Chief Financial Officer - Robert J. Park TAKEAWAYS Revenue -- $305 million, falling within management guidance ranges despite timing-related impacts in foundational audio. Non-GAAP EPS -- $0.69, exceeding the midpoint of guidance as lower operating expenses helped offset revenue shifts.

Audio and video technology company Dolby Laboratories (NYSE: DLB) missed Wall Street’s revenue expectations in Q2 CY2026, with sales falling 3.3% year on year to $305 million. On the other hand, next quarter’s outlook exceeded expectations with revenue guided to $377 million at the midpoint, or 7.4% above analysts’ estimates. Its non-GAAP profit of $0.69 per share was 3% above analysts’ consensus estimates. Is now the time to buy Dolby Laboratories?

Copyright 2026 PR Newswire. All Rights Reserved 2026-07-30 SAN FRANCISCO, July 30, 2026 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE:DLB) today announced the company's financial results for the third quarter of fiscal 2026. "We continue to execute against our full-year objectives, and we are building momentum across several of our key growth areas," said Kevin Yeaman, President and CEO, Dolby Laboratories.

Dolby Laboratories, Inc. (DLB) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d165402dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 Dolby Laboratories Reports Third Quarter 2026 Financial Results SAN FRANCISCO, July 30, 2026 — Dolby Laboratories, Inc. (NYSE:DLB) today announced the company’s financial results for the third quarter of fiscal 2026. “We co

Pendleton Todd (SVP, Chief Marketing Officer) sold 11,876 shares of Dolby Laboratories, Inc. (DLB) at $54.55 ($0.65M total) on 2026-05-22.

Shriram Revankar, Senior Vice President at Dolby Laboratories, sold 3,000 shares of company stock for $164,700 on May 15, 2026, executed via a pre-arranged trading plan. This sale occurred while the stock was near its 52-week low, despite recent positive Q2 2026 earnings where Dolby surpassed EPS and revenue forecasts. The company also disposed of shares to cover withholding taxes, and Revankar now holds 76,274 shares including restricted stock units.